Today on Pharmaceutical Processing
Bayer plans to build $2.2B Ohio drug manufacturing site
Bayer plans to put $2.2 billion toward the construction of a new drug production site in Ohio, with a starting focus in oncology, cardiovascular and kidney therapies. Described as a modular campus that will span drug substance and product manufacturing, the site outside Columbus in New Albany is slated to create about 600 new jobs.…
GSK invests another $800M in Pennsylvania site expansions
GSK is expanding its footprint in Pennsylvania, with plans to invest $800 million in a biopharma research and manufacturing hub that’s expected to create more than 300 jobs in the next five years. New construction is slated to begin next year at facilities in Upper Merion Township outside Philadelphia, near the drugmaker’s U.S. headquarters —…
Sponsored Content See More >
Advancing Pressure Protection in Biopharma: How Integrated Bypass Technology Elevates Single-Use Pump Designby Michael Irving, Xylem In pharmaceutical and biopharmaceutical manufacturing, there is zero margin for error when it comes to process…
Accelerating pharmaceutical manufacturing digitalization with low-code developmentPharmaceutical manufacturers don’t just need digitalization – they need speed. Traditional MES deployment timelines, often stretching from 8 to 24…
Leading Pharmacy Automation Companies Transforming Health CareThe rising demand for accuracy, efficiency and real-time visibility has made pharmacy automation an integral part of both retail and…
Digital Transformation in the Pharmaceutical IndustryGrundfos Industry Experts A leading global pharmaceutical manufacturing company, ranked among the top 20 worldwide, sought to optimize operational efficiencies…
Raumedic: A Trusted Partner in Serving the Pharmaceutical Industry with the Gold Standard in Silicone TubingRaumedic is a trusted partner in the international medical technology and pharmaceutical industry. The medical division of the global corporation…
Personalized medicine: advanced technology is saving livesThe concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies…
MES for Flexible, Paperless Pharmaceutical ProductionAll companies in the pharmaceutical industry are under pressure for time, quality, compliance, and innovation. These pressures create imperatives to…
Pave the way to high productivity with continuous manufacturing for pharmaContinuous manufacturing in the pharmaceutical industry is increasing as more manufacturers realize the benefits of the technology. But no two…
Revolutionizing Pharma Sustainability: Grundfos Solutions for Optimizing EfficiencyThis white paper highlights the pressing need for sustainability in the pharmaceutical industry, where energy-intensive processes contribute significantly to environmental…
The Evolution of Heat Sealingby Charles H. Trillich / Co-Founder Packworld USA Heat sealing technology has evolved over many decades to reduce cost and…
Difficult transmembrane protein targets for therapeutic antibodiesWhat is the current landscape of antibodies targeting membrane proteins? As of June 2022, 162 antibodies had been approved for…
Validatable Band Sealers for Medical PouchesBy Lynn Miranda, Sales Manager for All Packaging Machinery Corp, Ronkonkoma, NY. The customer’s level of confidence and trust is…
Regulatory See More >
AI in clinical trials: practical uses and limits
Indero’s Guillaume Gigon on where AI helps clinical trials, from protocol drafting to data validation, and why data quality and oversight set its limits.
Learn how to rapidly develop smart and sustainable engineering and production processes See More >
Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >
GSK invests another $800M in Pennsylvania site expansions
GSK is expanding its footprint in Pennsylvania, with plans to invest $800 million in a biopharma research and manufacturing hub that’s expected to create more than 300 jobs in the next five years. New construction is slated to begin next year at facilities in Upper Merion Township outside Philadelphia, near the drugmaker’s U.S. headquarters —…
Supply Chain See More >
Bayer plans to build $2.2B Ohio drug manufacturing site
Bayer plans to put $2.2 billion toward the construction of a new drug production site in Ohio, with a starting focus in oncology, cardiovascular and kidney therapies. Described as a modular campus that will span drug substance and product manufacturing, the site outside Columbus in New Albany is slated to create about 600 new jobs.…
Recalls See More >
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…
